📖 OA 비율이 비슷한 저널 — 이 저널 26.4% 기준 ±5pp
전체 논문 (239편 · 1/8)
-
Heterogeneity in endocrine monitoring and timing of endocrinology involvement during immune checkpoint inhibitor therapy: A Real-World Single-Center study.
-
Utility of Cell-Free DNA integrity index in differentiating malignant from benign lesions in indeterminate thyroid nodules.
-
Pediatric follicular thyroid carcinoma: a clinicopathologic study treated at a single institution during a 30-year period.
-
Health-related quality of life and predictors in differentiated thyroid cancer patients during the transitional period: A Cross-sectional study.
-
Multifocal papillary thyroid carcinoma: the impact of multifocality metrics on the response to treatment.
-
The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy.
-
Anti-tumour effects of combined lenvatinib and EGFR Inhibition in advanced differentiated thyroid cancer cells.
-
De-escalation strategies in the management of differentiated thyroid cancer.
-
Comparative evaluation of dynamic risk stratification according to ATA 2015 and ATA 2025 in low-risk differentiated thyroid cancer without radioiodine ablation.
-
Thyroid cancer and thyroid nodules in acromegaly: a single-center retrospective study.
-
Risk factors for lung metastasis in children and adolescent patients with papillary thyroid cancer: A retrospective cohort study.
-
Evaluation of a conversation aid for patients with thyroid nodules considering a biopsy: pilot multicenter randomized control trial.
-
Symptom clusters and contemporaneous symptom network analysis at discharge in patients with differentiated thyroid cancer after thyroidectomy.
-
MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1.
-
BRAF/MEK inhibitors for redifferentiation in patients with radioiodine refractory thyroid cancer: A systematic review and Meta-Analysis.
-
Comprehensive evaluation of TIR 3B thyroid nodules: Clinical, Ultrasonographical and Cytological features for prediction of malignancy.
-
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro.
-
Validation of the Czech version of the nine-item Fear of Cancer Recurrence Inventory in differentiated thyroid cancer survivors.
-
Evaluating the Completeness of Thyroid Nodule Ultrasound Reporting Using Natural Language Processing.
-
Alterations in gut microbiota and metabolic profiling are associated with papillary thyroid cancer and BRAF mutation.
-
Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer.
-
Bisphenols and their role in female infertility and hormone-related cancer.
-
Sex differences in the onset and outcomes of immune checkpoint inhibitor-induced overt thyroid dysfunction: a retrospective study.
-
The impact of Hashimoto's thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: a propensity score matching study.
-
Prognostic significance of metastatic lymph node size and extra-nodal extension in papillary thyroid carcinoma according to the 9th edition of general rules for the description of thyroid cancer risk stratification: a single center validation study.
-
Investigation of the causal relationship between breast cancer and thyroid cancer: a set of two-sample bidirectional Mendelian randomization study.
-
POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation.
-
The influence of cancer on the reprogramming of lipid metabolism in healthy thyroid tissues of patients with papillary thyroid carcinoma.
-
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature.
-
Standard operating procedure (SOP) for cervical ultrasound cine loop video sequences in the follow-up of differentiated thyroid carcinoma (DTC).